TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06576570

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Education presentation of surgical ergonomics
Description: During an individual meeting with participant, a brief presentation will be supplied for review.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Summary of Ergonomic Measurement System
Description: Participant will view a video of their movements with a visual guideline highlighting high-risk angles and movements.
Study: NCT04681937

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subacromial Injection (hyaluronic acid) + Physical Therapy.
Description: arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subacromial Injection (Platelet-Rich-Plasma) + Physical Therapy.
Description: arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subacromial Injection (methylprednisolone acetate) + Physical Therapy.
Description: arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subacromial Injection (Serum Saline) + Physical Therapy.
Description: arm1: sodium hyaluronate (4ml) arm2: platelet-rich-plasma (4ml) arm3: methylprednisolone acetate (1ml methylprednisolone acetate + 3 ml serum saline) arm4: serum saline (4ml) The same physical therapy procedure will be applied to all arms after injection.
Study: NCT01093300

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting balloon catheter

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Everolimus-eluting stent
Study: NCT06285760

Intervention type: DRUG
Intervention: Standarized diuretic therapy
Description: Patients hospitalized with decompensated heart failure and fluid overload who require diuretic treatment for relieve of congestion. Standarized diuretic protocol according to guidelines will be applied. It consists of intravenous furosemide, SGLT2 inhibitors and acetazolamide if congestion persist.
Study: NCT04468243

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led diabetes care
Description: Nurse-led brief diabetes education, instructions on glucometer and Metformin use, patients receive prescriptions for Metformin and blood glucose testing kit
Study: NCT06561542

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LX22001 for Injeciton
Description: single dose: 25mg,50mg,100mg,200mg ,intravenous infusion. repeat doses: 50mg,100mg , intravenous infusion,once daily for 3 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegoprazan tablet
Description: 50mg,oral,single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole sodium for injection
Description: 80 mg intravenous infusion for 30 min followed by a continuous infusion of 8 mg/h for 71.5h
Study: NCT05120388

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extra Virgin Olive Oil Addition
Description: Daily dietary addition of olive oil (three tablespoons)
Study: NCT06089057

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease
Description: This is a 16-week power-training and physical activity-focused intervention that contains group in-center and individual at-home components and motivational coaching. Participants will meet 2-3 times per week for the in-center power training. Participants will also be asked to wear accelerometers at home in order for their physical activity frequency to be measured.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control for Pro-social Power training Activity for Aging and Well-being with Chronic Kidney Disease
Description: This will be the attention control arm that will involve receipt of a physical activity education booklet, use of an accelerometer, and weekly check-in calls. No power training or motivational coaching will be delivered.
Study: NCT05507489

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Jinzhen oral liquid or Jinhuaqinggan granules
Description: Jinzhen oral liquid, for 3 years old, 10 ml once, twice a day; for 4 to 7 years old, 10 ml a time, 3 times a day; for 8 to 18 years old, 15 ml a time, 3 times a day.The dosage and usage of Jinhua Qinggan granules were determined by the researcher according to the patient's condition. The drugs were medicated for 14 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jinzhen oral liquid or Jinhuaqinggan granules
Description: Jinzhen oral liquid, for 3 years old, 10 ml once, twice a day; for 4 to 7 years old, 10 ml a time, 3 times a day; for 8 to 18 years old, 15 ml a time, 3 times a day.The dosage and usage of Jinhua Qinggan granules were determined by the researcher according to the patient's condition. The drugs were medicated for 14 days.
Study: NCT05536674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminder for the HPV vaccination
Description: A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminder for the HPV vaccination
Description: A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminder for the HPV vaccination
Description: A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS reminder for the HPV vaccination
Description: A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.
Study: NCT05053360

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healing Touch
Description: Healing Touch (HT), with a foundation in holistic nursing, is a gentle therapy that uses touch to promote health and well-being by balancing the human energy system. Healing Touch (HT) is a biofield therapy in which practitioners use their hands in a heart-centered and intentional way to provide energetic balance to support physical, emotional, mental and spiritual health. It is safe for all ages and works in harmony with, is complementary to, and may be integrated with standard medical care. Healing Touch is a collection of standardized, noninvasive techniques that clear, energize, and balance the human and~environmental energy fields.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Quiet Time (QT) session is when a subject is provided with quiet for 15 minutes
Study: NCT06250153

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)
Description: M-SBIRT is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder treatment services.
Study: NCT06307444

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-Guided Stellate Ganglion Block
Description: high frequency (6 to 13 MHz) linear transducer will be placed perpendicular to the tracheal axis at the cricoid cartilage and will be moved inferiorly until the superior aspect of the thyroid gland is visualized. Later, the transducer should be relocated laterally to visualize the anterior aspect of the Chassaignac's tubercle on \[\]the C6 transverse process. The carotid artery, internal jugular vein, thyroid gland, trachea, Longus colli, and Longus capitis muscle, prevertebral fascia, the root of C6 spinal nerve, and transverse process of C6 can be identified. Color Doppler will be used to detect the position of the vessels. With an in-plane approach, 22 to 25 gauge echo-enhanced needle is placed beside the trachea with a lateral to medial direction.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: T2 T3 (High Thorathic) ESP Block
Description: We will count the laminae in the cephaled-to-caudal direction, starting from the C7 using the US to determine the exact vertebral level where the needle will be inserted. A linear high-frequency ultrasound probe will be used to perform the blocks. After the determination of the needle insertion site, the US probe was placed over the spinous processes of the vertebrae at the midline in the longitudinal plane. The US probe will then slid laterally from the spinous processes to visualize the transverse process. The needle will be advanced posterior-to-anteriorly, in the caudal to cephalic direction using the in-plane orientation within paraspinal muscles, targeting the transverse process. When the tip of the needle reaches and contact the transverse process, the local anesthetic drugs(0.2-0.3ml/kg(11) of bupivacaine 0.25% 8mg Dexamethazone) will be administered
Study: NCT05206227

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Subjects will complete a single bout of aerobic exercise.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Subjects will complete a single bout of aerobic exercise.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alpha-FMH
Description: Subjects will undergo either local heating with diathermy or whole body heating with far-infrared sauna.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance and Aerobic Exercise
Description: Subjects will complete bouts of resistance and aerobic exercise.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antihistamine
Description: Subjects will complete a single bout of aerobic exercise under placebo vs antihistamine conditions.
Study: NCT05979272

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: Treatment as Usual at the local family court, which includes a brief, computerized motivation enhancement intervention. All CINI youth will receive TAU, regardless of condition.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as Usual at the local family court, which includes a brief, computerized motivation enhancement intervention. All CINI youth will receive TAU, regardless of condition.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teen Empowerment through Computerized Health (TECH) app
Description: An adjunct smartphone app (i.e., TECH) developed to support TAU. All participants randomly assigned to TAU+TECH will receive the TECH app.
Study: NCT05621044

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FitBrothers smartphone active app
Description: The FitBrothers smartphone active app is designed to assist African American men with adopting and maintaining PA. The app will be developed with significant input from African American men and contain self-monitoring, goal setting, reward, and educational components. The app will include additional elements including PA adoption strategies, competitions, incentives, health information, and greater compatibility with activity monitoring devices. The intervention is based on the Social Cognitive and Self-Determination theories and is culturally tailored.
Study: NCT04746872

Intervention type: DIAGNOSTIC_TEST
Intervention: Alinity m HR HPV
Description: A qualitative in vitro test that amplifies and detects HR HPV DNA in cervical tissue samples.
Study: NCT04757740

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: intra-articular Platelet rich fibrin and lidocaine
Description: intra-articular injection of 3.5 ml of 1% lidocaine and PRF mixture.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylprednisolone acetate and lidocaine
Description: intra-articular injection of Mixture of 40 mg of methylprednisolone acetate(1 ml) and 1% lidocaine (2.5 ml). intra-articular steroid
Study: NCT06515067

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: back massage
Description: back massage

Intervention type: OTHER
Group type: OTHER
Intervention: no ıntervention
Description: no ıntervention
Study: NCT05621044

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nike Training Club
Description: The app is designed to increase fitness in users through a variety of mechanisms. Users are able to track and monitor their physical activity level, set goals, engage in competitions, and upload activity data from a wearable. They will also be provided with preset workouts, receive guidance from an expert, and receive personalized plans that automatically adapt to user behavior.
Study: NCT05875831

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing
Description: Active Cycle of Breathing Technique to Improve Pulmonary Functions in Post-Surgical Patients

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Coughing
Description: Coughing to Improve Pulmonary Functions in Post-Surgical Patients
Study: NCT06184763

Intervention type: OTHER
Intervention: 6-minute walk test
Description: 6-minute walk test in a 40-metre corridor. Included patients are used to performing this test, which is part of the standard care performed during patient follow-up, at least once a year.~Parameters collected during the test: distance walked, minimum SpO2, average SpO2, maximum heart rate, average heart rate, average heart rate over the last 2 minutes, dyspnea scale.
Study: NCT06572033

Intervention type: BEHAVIORAL
Intervention: Simulation
Description: Observational study with simulations.
Study: NCT06446362

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMCHB-Based Breastfeeding Support Program
Description: This intervention includes a structured breastfeeding support program based on the Interaction Model of Client Health Behavior (IMCHB). It consists of:~Educational Sessions: Conducted during the last trimester of pregnancy to provide information and prepare mothers for breastfeeding.~Motivational Interviews: Conducted face-to-face at 1-3 days, 15 days, 30 days, 45 days, and 60 days postpartum to address individual challenges and provide personalized support.~Follow-Up Support: Two follow-up sessions via WhatsApp video calls at 4 and 5 months postpartum to reinforce the intervention and provide ongoing assistance.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Breastfeeding Education
Description: Participants receive the standard care provided at Family Health Centers, which includes routine breastfeeding education and support typically offered to new mothers. This standard care does not include the additional structured support interventions provided in the IMCHB-Based Breastfeeding Support Program.
Study: NCT06295120

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin 1.2 MIE 4 times daily
Description: The intervention is the duration of treatment with phenoxymethylpenicillin from 3 to 7 days. Dose and frequency of the treatment is the same in the different arms.
Study: NCT04706637

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evogliptin
Description: evogliptin 5mg + metformin, oral administration once a day for 48 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin
Description: dapagliflozin 10mg + metformin, oral administration once a day for 48 weeks
Study: NCT05726825

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Therapeutic Plasma Exchange (TPE)
Description: The TPE treatment will be initiated within 6 hrs after randomization. Duration of TPE treatment is approximately 120-180 minutes. An additional second TPE can be performed if the patient remains vasopressor dependent ≥ 0.4 ug/kg/min after 24 hours following the first TPE procedure.~Both unfractionated heparin (UFH) and citrate may be used as anticoagulant medication.~To ensure treatment comparability between different patients, we will replace plasma in a fixed ratio of 1.2 x the individual patient's total plasma fluid.
Study: NCT05614453

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab is an investigational, humanised-IgG4 monoclonal antibody with high affinity/binding specificity for PD-1. It is engineered to minimise binding to FcγR on macrophages to abrogate antibody-dependent cellular phagocytosis.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitravatinib
Description: Sitravatinib is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with potential anti-neoplastic activity.
Study: NCT04999280

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fiber Croissant (FIBCRO) Group
Description: Subjects will consume for 2 weeks at breakfast a fiber-enriched sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Croissant (CONCRO) Group
Description: Subjects will consume for 2 weeks at breakfast a sourdough croissant. All subjects will be requested not to change other dietary habits and their physical activity during the 2 week intervention period.
Study: NCT05869136

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype
Description: All the participants will undergo phase-I therapy. Oral hygiene instructions will be imparted and will be reinforced at each appointment.~Local anaesthesia in the form of xylocaine spray will be administered.~Hyaluronic acid:~HA will be injected in the attached gingiva and MN will be carried out 1mm below the gingival margin on the keratinized gingiva of the tooth to be treated with thirty-gauge (0.255 mm) lancet needles in the test group.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: microneedling for increasing gingival thickness in thin gingival phenotype
Description: All the participants will undergo phase-I therapy. Oral hygiene instructions will be imparted and will be reinforced at each appointment.~Local anaesthesia in the form of xylocaine spray will be administered and microneedling alone will be performed in control group
Study: NCT05947409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SMARTO ONE
Description: The SMARTO ONE® small molecule natural flavonoid compound product is provided by Beijing Jiafurui Biological Technology Co., Ltd. The intervention agent formula consists of extracts from Polygonum cuspidatum leaves, Fructus ligustri lucidi, Prunus mume, Semen ziziphi spinosae, celery, resistant maltodextrin, and steviol glycoside. Each package of the test product (3g) contains a total flavonoid content of 150mg.
Study: NCT06558812

Intervention type: DEVICE
Group type: OTHER
Intervention: prefabricated space maintainer
Description: i. Prefabricated band will be selected for the abutment tooth by measuring the mesiodistal diameter of the abutment tooth with a caliper and will be adjusted with the internal diameter of the prefabricated band.~ii. The loop will be selected based on the available mesiodistal space and buccolingual width of the abutment tooth, excessive length with be cut by cutting plier and will then place inside the band's tube by using a HOWE pliers.~iii. Cotton roll isolation will use, then will be cemented with glass ionomer,

Intervention type: DEVICE
Group type: OTHER
Intervention: conventional space maintainer
Description: i. A full arch Impressions will be taken with alginate material. ii. Impressions will be poured up using dental stone within 30 min of the impression taking.~iii. The children will be given an appointment for space maintainer insertion. iv. In the second visit , Cotton roll isolation will use, cementation will be performed with glass ionomer .
Study: NCT05576831

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Re-excision
Description: Re-excise (one take back only) Excise scar aiming for 1-2cm margin
Study: NCT06550661

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ba duan jin
Description: a kind of exercise
Study: NCT06563063

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flumazenil
Description: The dose determination for flumazenil followed a biased-coin up-and-down design. Starting with an initial dose of 5 mcg, if there was an improvement in respiratory distress, the biased-coin method was used to give the same dose in the next patient with a probability of 8/9, and a decreased dose of 5 mcg in the next patient with a probability of 1/9.
Study: NCT06430294

Intervention type: OTHER
Intervention: Spinal mobilisation
Description: Application of a force on pediatric manikins.
Study: NCT06062823

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib 40 MG
Description: Afatinib 40mg administered orally daily.
Study: NCT05392959

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg Tab
Description: Dapagliflozin 10 mg per day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for dapagliflozin film-coated tablets 10 mg